CSIMarket
 


Cen Biotech Inc  (CENB)
Other Ticker:  
 

Cen Biotech Inc's Total Debt to Equity

CENB's quarterly Total Debt to Equity and Total Debt, Equity growth


In III Quarter 2022 Cen Biotech Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Cen Biotech Inc achieved the lowest Total Debt to Equity in the third quarter 2022. While total ranking remained the same in the third quarter 2022 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of CENBīs Total Debt?
How valuable is the CENBīs Equity?


CENB Total Debt to Equity (Sep 30 2022)
III. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Debt Change 184.03 % -80.86 % -92.4 % -94.34 % -94.58 %
Total Debt to Equity MRQ - - - - -
CENB's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Debt Change -14.8 % 149.26 % 30.76 % 2.28 % -94.26 %



Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Cen Biotech Inc's Equity $ -2 Millions Visit CENB's Balance sheet
Cen Biotech Inc's Total Debt $ 2 Millions Visit CENB's Balance sheet
Source of CENB's Sales Visit CENB's Sales by Geography


Cumulative Cen Biotech Inc's Total Debt to Equity

CENB's Total Debt to Equity for the trailling 12 Months

CENB Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Debt TTM Growth 184.03 % -80.86 % -92.4 % -94.34 % -94.58 %
Total Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Debt TTM Growth -14.8 % 149.26 % 30.76 % 2.28 % -94.26 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2022 company had stockholder deficit.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry CENB recorded the lowest Total Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Debt to Equity Ratio?
What is the structure of CENBīs Total Debt?
How valuable is the CENBīs Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Đ 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com